# GLucobay M OBservation Study for Efficacy and Safety in Treatment of Type-2 Diabetes Patients

> **NCT01219582** · — · COMPLETED · sponsor: **Bayer** · enrollment: 9364 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** Glucobay M (Acarbose/Metformin, BAY81-9783)

## Key facts

- **NCT ID:** NCT01219582
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2012-01
- **Final completion:** 2012-12
- **Target enrollment:** 9364 (ACTUAL)
- **Last updated:** 2013-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01219582

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01219582, "GLucobay M OBservation Study for Efficacy and Safety in Treatment of Type-2 Diabetes Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01219582. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*